Howard V. Owens Jr.

Array ( [id] => 646541 [patent_doc_number] => RE039324 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-10-03 [patent_title] => 'Pyrimidine derivatives and oligonucleotides containing same' [patent_app_type] => reissue [patent_app_number] => 10/080074 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27562 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039324.pdf [firstpage_image] =>[orig_patent_app_number] => 10080074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924111 [patent_doc_number] => 20020115877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Silicon-containing compound and organic electroluminescence device using the same' [patent_app_type] => new [patent_app_number] => 10/062665 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19618 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115877.pdf [firstpage_image] =>[orig_patent_app_number] => 10062665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228514 [patent_doc_number] => 06696425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Method of treating dry eye disease with purinergic receptor agonists' [patent_app_type] => B2 [patent_app_number] => 10/027520 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9403 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696425.pdf [firstpage_image] =>[orig_patent_app_number] => 10027520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1203049 [patent_doc_number] => 06720418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-13 [patent_title] => 'Derivatized reduced malto-oligosaccharides' [patent_app_type] => B2 [patent_app_number] => 10/023077 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4569 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720418.pdf [firstpage_image] =>[orig_patent_app_number] => 10023077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688859 [patent_doc_number] => 20030032584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and method of use' [patent_app_type] => new [patent_app_number] => 09/998497 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19741 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032584.pdf [firstpage_image] =>[orig_patent_app_number] => 09998497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281549 [patent_doc_number] => 20040063926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'L-nucleic acid derivative and processes for the synthesis thereof' [patent_app_type] => new [patent_app_number] => 10/433004 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10427 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063926.pdf [firstpage_image] =>[orig_patent_app_number] => 10433004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936681 [patent_doc_number] => 20020061884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 10/012589 [patent_app_country] => US [patent_app_date] => 2001-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1642 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061884.pdf [firstpage_image] =>[orig_patent_app_number] => 10012589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083083 [patent_doc_number] => 20020082417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency' [patent_app_type] => new [patent_app_number] => 10/007451 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10314 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082417.pdf [firstpage_image] =>[orig_patent_app_number] => 10007451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653078 [patent_doc_number] => 20030008832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Method of inhibiting neoplastic cells with benzimidazole derivatives' [patent_app_type] => new [patent_app_number] => 10/003868 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22673 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008832.pdf [firstpage_image] =>[orig_patent_app_number] => 10003868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344121 [patent_doc_number] => 20020035111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B] indole derivatives' [patent_app_type] => new [patent_app_number] => 09/974271 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25948 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035111.pdf [firstpage_image] =>[orig_patent_app_number] => 09974271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645680 [patent_doc_number] => 07119184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Oligonucleotides having A-DNA form and B-DNA form conformational geometry' [patent_app_type] => utility [patent_app_number] => 09/970971 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 38224 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119184.pdf [firstpage_image] =>[orig_patent_app_number] => 09970971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343925 [patent_doc_number] => 20020035086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Acylated uridine and cytidine and uses thereof' [patent_app_type] => new [patent_app_number] => 09/964514 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12964 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035086.pdf [firstpage_image] =>[orig_patent_app_number] => 09964514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064123 [patent_doc_number] => 20020032161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Cyclodextrin compositions' [patent_app_type] => new [patent_app_number] => 09/963237 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3012 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032161.pdf [firstpage_image] =>[orig_patent_app_number] => 09963237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383064 [patent_doc_number] => 20020120130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => '2\' or 3\' -deoxy and 2\', 3\' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents' [patent_app_type] => new [patent_app_number] => 09/953187 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7231 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120130.pdf [firstpage_image] =>[orig_patent_app_number] => 09953187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159112 [patent_doc_number] => 20020147216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Mucin synthesis inhibitors' [patent_app_type] => new [patent_app_number] => 09/951906 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11969 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147216.pdf [firstpage_image] =>[orig_patent_app_number] => 09951906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511711 [patent_doc_number] => 20020025968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives' [patent_app_type] => new [patent_app_number] => 09/952769 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14497 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025968.pdf [firstpage_image] =>[orig_patent_app_number] => 09952769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711603 [patent_doc_number] => 07057033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Fractionated polydisperse compositions' [patent_app_type] => utility [patent_app_number] => 09/943574 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 15517 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/057/07057033.pdf [firstpage_image] =>[orig_patent_app_number] => 09943574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716418 [patent_doc_number] => 07053199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Nucleoside analogs and oligonucleotide derivatives containing these analogs' [patent_app_type] => utility [patent_app_number] => 10/363057 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7452 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053199.pdf [firstpage_image] =>[orig_patent_app_number] => 10363057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253801 [patent_doc_number] => 06670458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Process for preparation of L-ribose using 1,4-lactone' [patent_app_type] => B2 [patent_app_number] => 09/931020 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4364 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 338 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670458.pdf [firstpage_image] =>[orig_patent_app_number] => 09931020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653125 [patent_doc_number] => 20030008841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Anti-HCV nucleoside derivatives' [patent_app_type] => new [patent_app_number] => 09/923620 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34616 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008841.pdf [firstpage_image] =>[orig_patent_app_number] => 09923620 [rel_patent_id] =>[rel_patent_doc_number] =>)